Highlights
NASDAQ: NERV       Minerva Neuroscie
Last Price Today's Change   Day's Range   Trading Volume
2.89   -1.00 (25.71%)  2.87 - 3.25  3,787,200

Overview

 
Avg Volume (4 weeks):622,400
4 Weeks Range:2.87 - 4.115
4 Weeks Price Volatility (%):
1.61%
52 Weeks Range:1.81 - 15.215
52 Weeks Price Volatility (%):
8.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. This portfolio includes four compounds, schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3870  4898  471  141 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.653-0.076 
 BB 7.00+1.13 
 EARS 5.23+4.12 
 ZOM 0.179+0.031 
 JAGX 0.458+0.108 
 NIO 45.36-5.17 
 HEXO 1.07-0.05 
 ONTX 0.373+0.083 
 AAPL 122.72+3.67 
 MRNA 141.01-11.73